PR

Prestige Biologics Co., Ltd.

A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.

334970 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명1로 197, 청주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Prestige Biologics Co., Ltd. is a global biopharmaceutical Contract Development and Engineering Manufacturing Organization (CDEMO) offering end-to-end solutions for the entire lifecycle of antibody-based therapeutics and other biologics. The company provides a full suite of services, from initial cell line and process development to analytical testing and manufacturing of drug substances and products for both clinical trials and commercial supply. Operating within GMP-compliant facilities, Prestige Biologics also supports clients with secondary packaging, logistics, and transportation for clinical trials, positioning itself as an integrated partner for biopharmaceutical innovators.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Prestige Biologics Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-19 00:00
Audit Report / Information
사업보고서 (2025.06)
Korean 493.5 KB
2025-09-18 00:00
Audit Report / Information
감사보고서제출
Korean 18.5 KB
2025-09-15 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 176.8 KB
2025-09-12 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 25.6 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 148.4 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 20.3 KB

Automate Your Workflow. Get a real-time feed of all Prestige Biologics Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prestige Biologics Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea 293480
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea 128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden HNSA
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan 4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan 219A
HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea 376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland HRTIS

Talk to a Data Expert

Have a question? We'll get back to you promptly.